河南省免疫與靶向藥物重點(diǎn)實(shí)驗(yàn)室
 網(wǎng)站首頁(yè) | 實(shí)驗(yàn)室簡(jiǎn)介 | 科研隊(duì)伍 | 科學(xué)研究 | 研究生培養(yǎng) | 科研成果 | 新聞動(dòng)態(tài) | 規(guī)章制度 
科研隊(duì)伍
王輝
當(dāng)前位置: 網(wǎng)站首頁(yè)>>科研隊(duì)伍>>師資力量>>正文

郭春磊

2022年07月08日 21時(shí)15分  點(diǎn)擊:[]

說(shuō)明: C:\Users\Administrator\Desktop\照片\guochunlei.jpg

郭春磊,南開(kāi)大學(xué)理學(xué)博士,副教授,碩士生導(dǎo)師,2017年至今就職于新鄉(xiāng)醫(yī)學(xué)院醫(yī)學(xué)檢驗(yàn)學(xué)院。目前的研究方向?yàn)槟[瘤免疫,主要從事腫瘤干細(xì)胞與腫瘤微環(huán)境之間相互調(diào)控的機(jī)制研究。累計(jì)主持國(guó)家自然科學(xué)基金1項(xiàng),河南省高校重點(diǎn)科研項(xiàng)目1項(xiàng),在Theranostics、Front Bioeng Biotechnol、Int J Pharm等雜志發(fā)表SCI論文7篇。

【研究工作經(jīng)歷】

2017.07-2021.12 新鄉(xiāng)醫(yī)學(xué)院醫(yī)學(xué)檢驗(yàn)學(xué)院 講師

2022.01-至今 新鄉(xiāng)醫(yī)學(xué)院醫(yī)學(xué)檢驗(yàn)學(xué)院 副教授

【承擔(dān)及完成課題】

1. FBF1促進(jìn)乳腺癌細(xì)胞干性和侵襲轉(zhuǎn)移的機(jī)制研究,國(guó)家自然科學(xué)基金青年項(xiàng)目,2019.01--2021.12,主持,21萬(wàn)元。

2. FBF1調(diào)控腫瘤干細(xì)胞特性促進(jìn)乳腺癌血管新生的機(jī)制研究,河南省高等學(xué)校重點(diǎn)科研項(xiàng)目,2019.01--2020.12,主持,5萬(wàn)元。

3.炎癥相關(guān)基因調(diào)控腫瘤細(xì)胞干性和轉(zhuǎn)移的機(jī)制研究,博士啟動(dòng)基金,主持,50萬(wàn)元。

【代表性論著】(#為第一作者,*為通訊作者)

1.Guo Chunlei#, Chen Yanan#, Gao Wenjuan, Chang Antao, Ye Yujie, Shen Wenzhi, Luo Yunping, Yang Shengyong, Sun Peiqing, Xiang Rong*, and Li Na*. Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models. Theranostics. 2017 ;7(3):775-788.

2.Guo Chunlei#, Li Shuang#, Liang Ang, Cui Mengchao, Lou Yunwei and Wang Hui*. PPA1 Promotes Breast Cancer Proliferation and Metastasis Through PI3K/AKT/GSK3β Signaling Pathway. Frontiers in Cell and Developmental Biology. 2021;9:730558.

3.Liu Hui#,Guo Chunlei#,Shang Yuhong, Zeng Lin, Jia Haixue, and Wang Zhongyan*. A Supramolecular Nanoparticle of Pemetrexed Improves the Anti-Tumor Effect by Inhibiting Mitochondrial Energy Metabolism. Front Bioeng Biotechnol. 2021 ;9:804747.

4.Hou Jie,Guo Chunlei, Shi Yuzhi, Liu Ergang, Dong Weibing, Yu Bo, Liu Shiyuan, Gong Junbo*. A novel high drug loading mussel-inspired polydopamine hybrid nanoparticle as a pH-sensitive vehicle for drug delivery. Int J Pharm. 2017 ;533(1):73-83.

5. Zhen Ye,Chunlei Guo, Wenzhi Shen, Shuangtao Zhao, Na Luo, Rongrong Wang, Xiaohe Luo, Haiying Niu, Dehong Luo, Shan Jiang, Xiaoyue Tan*, Rong Xiang*. Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis. Sci Rep. 2015 ;5:16599.

6. Liu Bowen, Cao Jinling, Wang Xiangyun,Guo Chunlei, Liu Yunxia and Wang Tianjiao. Deciphering the tRNA-derived small RNAs: origin, development, and future. Cell Death Dis. 2021 ;13(1):24.

7. Liu Hui, Zeng Lin, Yang Yang,Guo Chunleiand Wang Hui*. Bcl-3: A Double-Edged Sword in Immune Cells and Inflammation. Front Immunol. 2022 ;13: 847699.

上一條:化瑞芳 下一條:段良偉

關(guān)閉

地址:河南省新鄉(xiāng)市紅旗區(qū)金穗大道601號(hào)

版權(quán)所有:河南省免疫與靶向藥物重點(diǎn)實(shí)驗(yàn)室